Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer

A Deep Convolutional Neural Network for segmenting and classifying epithelial and stromal regions in histopathological images

(2016) Jun Xu et al.   NEUROCOMPUTING

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment

(2016) Niamh E. Buckley et al.   Scientific Reports

Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis

(2016) Geert Litjens et al.   Scientific Reports

Deep learning

(2015) Yann LeCun et al.   NATURE

Quantitative histology analysis of the ovarian tumour microenvironment

(2015) Chunyan Lan et al.   Scientific Reports

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

(2014) Peter A. Kaufman et al.   CANCER

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Pathologist Workforce in the United States: I. Development of a Predictive Model to Examine Factors Influencing Supply

(2013) Stanley J. Robboy et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

P1-07-02: Discordance between Central and Local Laboratory HER2 Testing from a Large HER2−Negative Population in VIRGO, a Metastatic Breast Cancer Registry.

(2012) CL Vogel et al.   CANCER RESEARCH

Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue

(2012) Steven J Potts et al.   LABORATORY INVESTIGATION

Evaluation of immunohistochemical staining using whole-slide imaging for HER2 scoring of breast cancer in comparison with real glass slides

(2012) Yuzuru Kondo et al.   PATHOLOGY INTERNATIONAL

Treatment of HER2-positive breast cancer: current status and future perspectives

(2011) Carlos L. Arteaga et al.   Nature Reviews Clinical Oncology

Predictive biomarkers: a paradigm shift towards personalized cancer medicine

(2011) Nicholas B. La Thangue et al.   Nature Reviews Clinical Oncology

Computer-aided Diagnosis: How to Move from the Laboratory to the Clinic

(2011) Bram van Ginneken et al.   RADIOLOGY

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment

(2009) J. M. Bueno-de-Mesquita et al.   ANNALS OF ONCOLOGY